MYLAN AUSTRALIA PTY LIMITED — Erythromycin Importer Profile
Pharmaceutical Importer · #6 buyer for Erythromycin · $1.0M import value · 54 shipments · AUSTRALIA · DGFT Verified
MYLAN AUSTRALIA PTY LIMITED is the #6 importer of Erythromycin from India with $1.0M in import value and 54 verified shipments. MYLAN AUSTRALIA PTY LIMITED holds a 1.3% market share in Erythromycin imports based in AUSTRALIA. The company sources from 1 verified supplier across 28 formulations shipped to 1 country. Overall, MYLAN AUSTRALIA PTY LIMITED imports 3 pharmaceutical products worth $4.8M across 3 therapeutic categories.
MYLAN AUSTRALIA PTY LIMITED — Erythromycin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Erythromycin to MYLAN AUSTRALIA PTY LIMITED?
Verified from 54 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MEDREICH LIMITED | $1.0M | 54 | 100.0% |
MYLAN AUSTRALIA PTY LIMITED sources Erythromycin from 1 verified Indian supplier based on 54 customs records. The primary supplier is MEDREICH LIMITED accounting for 100.0% of imports.
How Does MYLAN AUSTRALIA PTY LIMITED Compare to Nearest Erythromycin Importers?
Buyers ranked immediately above and below #6 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | ACE HEALTH CARE LDA | MOZAMBIQUE | $1.2M | 38 | $32.9K |
| 6 | MYLAN AUSTRALIA PTY LIMITED ★ | AUSTRALIA | $1.1M | 54 | $19.8K |
| 8 | LIFESCIENCE LOGISTICS | UNITED STATES | $989.1K | 40 | $24.7K |
| 9 | VIATRIS NEW ZEALAND | NEW ZEALAND | $901.7K | 33 | $27.3K |
MYLAN AUSTRALIA PTY LIMITED ranks #6 among 992 Erythromycin importers from India. Average shipment value of $19.8K compared to the market average of $8.6K. The closest competitors by value are ACE HEALTH CARE LDA and LIFESCIENCE LOGISTICS.
Where Does MYLAN AUSTRALIA PTY LIMITED Import Erythromycin To?
Destination countries from 54 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $1.0M | 54 | 100.0% |
MYLAN AUSTRALIA PTY LIMITED imports Erythromycin to 1 country. The primary destination is AUSTRALIA receiving 100.0% of shipments worth $1.0M.
What Erythromycin Formulations Does MYLAN AUSTRALIA PTY LIMITED Import?
| Formulation | Value | Shipments |
|---|---|---|
| ERYTHROMYCIN ETHYLSUCCINATE POWDER FOR O | $243.3K | 17 |
| E-MYCIN (ERYTHROMYCIN ETHYLSUCCINATE TAB | $105.7K | 3 |
| E-MYCIN (ERYTHROMYCIN ETHYLSUCCINATE TABLETS 400MG) 25S (52320 PACKS) | $92.4K | 3 |
| ERYTHROMYCIN ETHYLSUCCCINATE POWDER FOR | $74.6K | 5 |
| E-MYCIN (ERYTHROMYCIN ETHYLSUCCINATE TA | $49.6K | 1 |
| ERYTHROMYCIN ETHYLSUCCINATE POWDER FOR ORAL SUSPENSION 400MG/5ML E-MYCIN 400 100ML 13800 PACKS | $49.1K | 2 |
| E-MYCIN ERYTHROMYCIN ETHYLSUCCINATE TABLETS 400MG 25S 27520 PACKS | $49.0K | 1 |
| ERYTHROMYCIN ETHYLSUCCINATE POWDER FOR ORAL SUSPENSION 400MG/5ML E-MYCIN 400 100ML 13740 PACKS | $48.9K | 2 |
| E-MYCIN ERYTHROMYCIN ETHYLSUCCINATE TABLETS 400MG 25S 27200 PACKS | $48.4K | 1 |
| E-MYCIN (ERYTHROMYCIN ETHYLSUCCINATE TABLETS 400MG) 25S (27200 PACKS) | $46.8K | 1 |
MYLAN AUSTRALIA PTY LIMITED imports 28 distinct Erythromycin formulations from India. The top formulation is ERYTHROMYCIN ETHYLSUCCINATE POWDER FOR O with 17 shipments worth $243.3K.
Regulatory Requirements: Importing Erythromycin into Australia
What MYLAN AUSTRALIA PTY LIMITED and other importers must comply with to import Erythromycin from India
Regulatory Authority
Therapeutic Goods Administration (TGA)
Approval Process for Generic Erythromycin
Application for registration on the Australian Register of Therapeutic Goods (ARTG). Generic pathway requires bioequivalence and quality data per TGA guidelines.
Typical timeline: 10–14 months
GMP Requirements
TGA GMP clearance; PIC/S-aligned inspection of overseas manufacturing facilities
Import Licence & Documentation
TGA manufacturing licence or sponsor licence for import; GMP clearance for each manufacturing site
Labeling & Packaging
Australian-specific labeling per TGO 91/92; English language; AUST R number
Note: TGA participates in PIC/S mutual recognition — PIC/S GMP certificate from India may expedite clearance.
Regulatory information is provided for general reference based on publicly available TGA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with TGA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Erythromycin from India and How Much Does MYLAN AUSTRALIA PTY LIMITED Import?
India exported $8.5M worth of Erythromycin through 3,939 shipments from 368 suppliers to 135 countries, serving 992 buyers globally. MYLAN AUSTRALIA PTY LIMITED imports $1.0M of this total, accounting for 1.3% of India's Erythromycin exports with 54 shipments from AUSTRALIA. This is verified from 54 customs shipment records covering 28 distinct formulations.
What Is the Average Order Value for MYLAN AUSTRALIA PTY LIMITED's Erythromycin Imports?
MYLAN AUSTRALIA PTY LIMITED's average Erythromycin order value is $19.0K per consignment, based on 54 shipments totaling $1.0M. MYLAN AUSTRALIA PTY LIMITED is based in AUSTRALIA and ranks #6 among all Erythromycin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Erythromycin to MYLAN AUSTRALIA PTY LIMITED?
MYLAN AUSTRALIA PTY LIMITED sources Erythromycin from 1 verified Indian supplier: MEDREICH LIMITED ($1.0M, 100.0%). This is based on 54 customs records.
How Does MYLAN AUSTRALIA PTY LIMITED Compare to Other Erythromycin Importers?
MYLAN AUSTRALIA PTY LIMITED ranks #6 among 992 Erythromycin importers from India with a 1.3% market share. The top 3 importers are ACE HEALTH CARE LDA ($1.2M), MYLAN AUSTRALIA PTY LIMITED ($1.1M), LIFESCIENCE LOGISTICS ($989.1K). MYLAN AUSTRALIA PTY LIMITED processed 54 shipments from AUSTRALIA.
About MYLAN AUSTRALIA PTY LIMITED
MYLAN AUSTRALIA PTY LIMITED imports 3 products worth $4.8M. Beyond Erythromycin, top products include Flucloxacillin, Brufen. View the complete MYLAN AUSTRALIA PTY LIMITED profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Erythromycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Erythromycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: MYLAN AUSTRALIA PTY LIMITED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as MYLAN AUSTRALIA PTY LIMITED's capped import value divided by total capped export value for Erythromycin across all Indian exporters.
- 5.Verified Records: This page is backed by 54 individual customs records matching MYLAN AUSTRALIA PTY LIMITED importing Erythromycin, covering 28 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 135+ countries, 992+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Erythromycin Import Data for MYLAN AUSTRALIA PTY LIMITED
Access order-level details, pricing data, supplier connections, and competitive analysis for MYLAN AUSTRALIA PTY LIMITED's Erythromycin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MYLAN AUSTRALIA PTY LIMITED
Full Company Profile →
3 products · $4.8M total trade · 3 categories
MYLAN AUSTRALIA PTY LIMITED × Erythromycin
Verified from customs records
Company Overview
Top Products by MYLAN AUSTRALIA PTY LIMITED
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for MYLAN AUSTRALIA PTY LIMITED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Erythromycin. For current order-level data, contact TransData Nexus.